Absorption |
Blood-Brain Barrier | BBB+ | 0.9729 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8241 |
P-glycoprotein Substrate | Substrate | 0.6099 |
P-glycoprotein Inhibitor | Inhibitor | 0.8228 |
Inhibitor | 0.5313 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6770 |
Distribution |
Subcellular localization | Mitochondria | 0.4737 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8584 |
CYP450 2D6 Substrate | Non-substrate | 0.8460 |
CYP450 3A4 Substrate | Substrate | 0.7278 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7782 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8379 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9508 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6023 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7789 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8417 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7353 |
Non-inhibitor | 0.7458 |
AMES Toxicity | Non AMES toxic | 0.9438 |
Carcinogens | Non-carcinogens | 0.8946 |
Fish Toxicity | High FHMT | 0.9930 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8506 |
Honey Bee Toxicity | High HBT | 0.8529 |
Biodegradation | Not ready biodegradable | 0.9805 |
Acute Oral Toxicity | III | 0.8367 |
Carcinogenicity (Three-class) | Non-required | 0.4722 |